WellTheory

Series-A
welltheory.com Biotech & Healthcare San Francisco, United States
Total Funding $14M
Latest Round $14M Series-A
Last Announced Oct 24, 2025
Investors 3 Backers
Decision Makers 5 Verified

About WellTheory

Autoimmune conditions are rising faster than any other disease, now affecting over 50 million Americans. Yet they remain misunderstood, underdiagnosed, and overlooked. WellTheory is here to change that with a new kind of care that’s personalized, rooted in science, powered by AI, and delivered with compassion. We help people reduce symptoms, feel better, and live fuller lives — while helping employers and payors reduce their spend.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters San Francisco, United States
Tracked Since Sep 29, 2026

Web & Domain Identity

Official Website welltheory.com
Domain Registered Date Apr 6, 2016

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $14,000,000 · Series-A

    welltheory.com

  2. Milestone

    Website domain registered

    welltheory.com

Investors & Backers

3
Accel
BoxGroup
General Catalyst

Funding History

1 Round
Series-A · Oct 24, 2025
$14,000,000 welltheory.com

Founders & Leadership

1

Ellen Rudolph

CEO & Co-Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts